Results 31 to 40 of about 127,947 (249)
Predictive Ability of Plasma p‐tau217 for β‐Amyloid Status: A Prospective Multicenter Study
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Plasma tau phosphorylated at threonine 217 (p‐tau217) measured with fully automated platforms has shown high accuracy for Alzheimer's disease (AD) diagnosis, but real‐world multicenter data remain limited. We aimed to validate the diagnostic performance of p‐tau217 for identifying AD pathology in a real‐world multicenter cohort ...
Miquel Massons +33 more
wiley +1 more source
, 2013 Immunohistochemical double labeling for GFAP and BrdU shows single GFAP+ astrocytes in the hilus with their processes occasionally extending into the sgz.
Carlos E. N. Girardi (374771) +6 more
core +1 more source
GFAP densitometry (n = 5/group).
, 2022 Female LF Antibiotics revealed a significant decrease in GFAP densitometry in the hippocampus compared to Female LF. ** p < 0.01. Representative micrographs of images taken at 10X following labeling with a GFAP antibody are presented.
Nicaella Fogle (12359643) +11 more
core +1 more source
Dimethyl Fumarate, But Not Rituximab, Reduces Serum GFAP Levels and PIRMA in Relapsing–Remitting MS
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Serum neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP) levels are believed to reflect mainly acute and chronic disease processes in multiple sclerosis (MS), respectively. In this study, we investigated whether dimethyl fumarate (DMF) and rituximab (RTX) differentially affect these biomarkers.
F. Shawket +14 more
wiley +1 more source
Detection of GFAP and cit-GFAP in livers from sham-operated control and BDL mice.
, 2018 The expression levels of GFAP and cit-GFAP in the liver tissues of control and BDL mice were analyzed by western blot using rabbit polyclonal anti-GFAP (Abcam, Cambridge UK) and citrullinated GFAP (CTGF-122R and CTGF-1221) antibodies.
Hyoung Su Kim (847068) +12 more
core +1 more source
Image_1_Serological biomarkers in autoimmune GFAP astrocytopathy.tif
, 2022 Autoimmune glial fibrillary acidic protein astrocytopathy (GFAP-A) is a newly defined meningoencephalomyelitis. The pathogenesis of GFAP-A is not well understood.
Xin-Guang Yang (13186599) +9 more
core +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective To evaluate the expression of nine blood RNA biomarkers in a clinical trial based on genes previously identified in an experimental monkey model of stroke for diagnosis feasibility and prognostication. Methods IBIS‐CT1 was a prospective longitudinal study enrolling patients with ischemic stroke (IS) or intracerebral hemorrhage (ICH ...
Salomé Retailleau +11 more
wiley +1 more source
Table_3_Serological biomarkers in autoimmune GFAP astrocytopathy.xlsx
, 2022 Autoimmune glial fibrillary acidic protein astrocytopathy (GFAP-A) is a newly defined meningoencephalomyelitis. The pathogenesis of GFAP-A is not well understood.
Xin-Guang Yang (13186599) +9 more
core +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective To describe long‐term outcomes after anti‐CD20 discontinuation in selected patients with secondary progressive multiple sclerosis (SPMS) who remained without subsequent disease‐modifying therapy (DMT). Methods We retrospectively analyzed data from four centers in Austria and Switzerland.
Ferdinand Otto +12 more
wiley +1 more source
Spinal cord staining with GFAP.
, 2019 A: Representative photomicrographs (100x objective) of the ipsilateral ventral grey horn of L3-L6 spinal cords sections from all groups immunostained for GFAP (GFAP (GA-5): sc-58766, Mouse Monoclonal–Santa Cruz Biotechnology) at week 3 (A1, A3, A5, A7 ...
Waleed M. Renno (7645319) +2 more
core +1 more source